Baird Financial Group, Inc. Catalent, Inc. Transaction History

Baird Financial Group, Inc.

$50.2 Billion
Q3 2024

A detailed history of Baird Financial Group, Inc. transactions in Catalent, Inc. stock. As of the latest transaction made, Baird Financial Group, Inc. holds 6,861 shares of CTLT stock, worth $418,383. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,861

Previous 6,859 0.03%

Holding current value

$418,383

Previous $385,000 7.79%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$56.16 - $60.96 $112 - $121	2 Added 0.03%	6,861 $415,000
Q2 2024 Aug 13, 2024	SELL	$53.58 - $57.02 $474,879 - $505,368	-8,863 Reduced 56.37%	6,859 $385,000
Q1 2024 May 14, 2024	BUY	$42.56 - $59.82 $669,128 - $940,490	15,722 New	15,722 $887,000
Q2 2023 Aug 11, 2023	SELL	$31.86 - $67.26 $26.5 Million - $56 Million	-832,419 Reduced 98.8%	10,104 $438,000
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $427,454 - $698,563	9,407 Added 1.13%	842,523 $55.4 Million
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $1.03 Million - $1.61 Million	14,236 Added 2.19%	665,322 $48.1 Million
Q2 2022 Aug 08, 2022	BUY	$87.2 - $114.05 $1.26 Million - $1.64 Million	14,418 Added 2.26%	651,086 $69.9 Million
Q1 2022 May 13, 2022	BUY	$94.19 - $124.49 $1.41 Million - $1.86 Million	14,981 Added 2.41%	636,668 $70.6 Million
Q4 2021 Feb 09, 2022	SELL	$119.57 - $139.07 $2.78 Million - $3.23 Million	-23,236 Reduced 3.6%	621,687 $79.6 Million
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $1.42 Million - $1.85 Million	12,995 Added 2.06%	644,923 $85.8 Million
Q2 2021 Aug 11, 2021	SELL	$100.34 - $115.69 $17.7 Million - $20.4 Million	-176,543 Reduced 21.84%	631,928 $68.3 Million
Q1 2021 May 13, 2021	SELL	$101.51 - $125.27 $5.31 Million - $6.55 Million	-52,317 Reduced 6.08%	808,471 $85.1 Million
Q4 2020 Feb 11, 2021	SELL	$85.88 - $105.36 $1.17 Million - $1.43 Million	-13,584 Reduced 1.55%	860,788 $89.6 Million
Q3 2020 Nov 12, 2020	SELL	$72.74 - $92.5 $2.3 Million - $2.92 Million	-31,592 Reduced 3.49%	874,372 $74.9 Million
Q2 2020 Oct 22, 2020	BUY	$48.02 - $79.04 $43.3 Million - $71.3 Million	901,844 Added 21889.42%	905,964 $66.4 Million
Q2 2020 Aug 14, 2020	SELL	$48.02 - $79.04 $30,828 - $50,743	-642 Reduced 13.48%	4,120 $234,000
Q1 2020 May 14, 2020	BUY	$36.95 - $62.95 $32,405 - $55,207	877 Added 22.57%	4,762 $247,000
Q4 2019 Feb 14, 2020	BUY	$47.06 - $56.64 $182,828 - $220,046	3,885 New	3,885 $219,000

Others Institutions Holding CTLT

# of Institutions

513

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Account

Baird Financial Group, Inc. Catalent, Inc. Transaction History